At non-toxic doses, the four target compounds in O. vulgaris significantly reduced the secretion of TNF-α, IL-1β, IL-6, and NO, suggesting that O. vulgaris is a potential therapeutic agent for RA. This evidence concerns the gene IL1B and rheumatoid arthritis.